Premium
Daratumumab rapidly reduces high‐titre factor VIII inhibitors in haemophilia A patients during life‐threatening haemorrhages
Author(s) -
Moonla Chatphatai,
Uaprasert Noppacharn,
Watanaboonyongcharoen Phandee,
Meesanun Mukmanee,
Sukperm Autcharaporn,
Jantasing Ratchaneekorn,
Faknuam Saruta,
Chanswangphuwana Chantiya,
Polprasert Chantana,
Sodsai Pimpayao,
Akkawat Benjaporn,
Hirankarn Nattiya,
Bunworasate Udomsak,
Rojnuckarin Ponlapat
Publication year - 2021
Publication title -
haemophilia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.213
H-Index - 92
eISSN - 1365-2516
pISSN - 1351-8216
DOI - 10.1111/hae.14118
Subject(s) - medicine , haemophilia , daratumumab , haemophilia a , titer , content (measure theory) , pediatrics , immunology , antibody , mathematical analysis , mathematics , monoclonal antibody
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom